Avinger, Inc. (AVGR)
USD 0.47
(-20.74%)
USD 0.47
(-20.74%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -16.63 Million USD | -4.25% |
| 2022 | -15.95 Million USD | 11.84% |
| 2021 | -18.1 Million USD | -4.0% |
| 2020 | -17.4 Million USD | 10.1% |
| 2019 | -19.35 Million USD | 12.27% |
| 2018 | -22.06 Million USD | 48.14% |
| 2017 | -42.55 Million USD | 16.1% |
| 2016 | -50.71 Million USD | -24.64% |
| 2015 | -40.69 Million USD | -62.58% |
| 2014 | -25.02 Million USD | 32.31% |
| 2013 | -36.97 Million USD | -9.21% |
| 2012 | -33.85 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -4.12 Million USD | 18.9% |
| 2024 Q1 | -5.08 Million USD | -10.27% |
| 2023 Q4 | -4.61 Million USD | -14.43% |
| 2023 FY | -16.63 Million USD | -4.25% |
| 2023 Q2 | -3.72 Million USD | 12.42% |
| 2023 Q1 | -4.25 Million USD | -11.41% |
| 2023 Q3 | -4.03 Million USD | -8.15% |
| 2022 FY | -15.95 Million USD | 11.84% |
| 2022 Q4 | -3.82 Million USD | -3.86% |
| 2022 Q3 | -3.68 Million USD | 2.1% |
| 2022 Q2 | -3.75 Million USD | 19.95% |
| 2022 Q1 | -4.69 Million USD | -3.07% |
| 2021 FY | -18.1 Million USD | -4.0% |
| 2021 Q2 | -4.4 Million USD | 5.21% |
| 2021 Q3 | -4.48 Million USD | -1.86% |
| 2021 Q1 | -4.64 Million USD | -9.85% |
| 2021 Q4 | -4.55 Million USD | -1.49% |
| 2020 Q2 | -3.59 Million USD | 34.44% |
| 2020 Q3 | -4.1 Million USD | -14.17% |
| 2020 Q1 | -5.47 Million USD | -9.34% |
| 2020 Q4 | -4.23 Million USD | -3.19% |
| 2020 FY | -17.4 Million USD | 10.1% |
| 2019 Q2 | -4.7 Million USD | 6.39% |
| 2019 FY | -19.35 Million USD | 12.27% |
| 2019 Q4 | -5.01 Million USD | -8.58% |
| 2019 Q3 | -4.61 Million USD | 1.93% |
| 2019 Q1 | -5.02 Million USD | 13.77% |
| 2018 Q3 | -5.12 Million USD | 6.47% |
| 2018 FY | -22.06 Million USD | 48.14% |
| 2018 Q4 | -5.83 Million USD | -13.87% |
| 2018 Q2 | -5.47 Million USD | 2.99% |
| 2018 Q1 | -5.64 Million USD | 34.33% |
| 2017 Q2 | -11.26 Million USD | 18.52% |
| 2017 Q4 | -8.59 Million USD | 3.11% |
| 2017 Q1 | -13.82 Million USD | -15.55% |
| 2017 FY | -42.55 Million USD | 16.1% |
| 2017 Q3 | -8.86 Million USD | 21.27% |
| 2016 Q4 | -11.96 Million USD | -4.66% |
| 2016 FY | -50.71 Million USD | -24.64% |
| 2016 Q3 | -11.43 Million USD | 7.01% |
| 2016 Q2 | -12.29 Million USD | 18.2% |
| 2016 Q1 | -15.02 Million USD | -22.13% |
| 2015 FY | -40.69 Million USD | -62.58% |
| 2015 Q2 | -9.08 Million USD | 3.63% |
| 2015 Q1 | -9.42 Million USD | -35.13% |
| 2015 Q4 | -12.3 Million USD | -24.61% |
| 2015 Q3 | -9.87 Million USD | -8.73% |
| 2014 Q2 | -5.52 Million USD | 13.34% |
| 2014 Q3 | -6.14 Million USD | -11.16% |
| 2014 Q4 | -6.97 Million USD | -13.51% |
| 2014 Q1 | -6.37 Million USD | 14.24% |
| 2014 FY | -25.02 Million USD | 32.31% |
| 2013 Q3 | -8.44 Million USD | 19.95% |
| 2013 Q2 | -10.54 Million USD | 0.0% |
| 2013 FY | -36.97 Million USD | -9.21% |
| 2013 Q1 | -10.54 Million USD | 0.0% |
| 2013 Q4 | -7.43 Million USD | 11.89% |
| 2012 FY | -33.85 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 71.154% |
| AngioDynamics, Inc. | -97.71 Million USD | 82.977% |
| AtriCure, Inc. | -26.68 Million USD | 37.657% |
| Azenta, Inc. | -73.12 Million USD | 77.252% |
| BioLife Solutions, Inc. | -70.82 Million USD | 76.513% |
| The Cooper Companies, Inc. | 533.1 Million USD | 103.12% |
| Daxor Corporation | -177.07 Thousand USD | -9294.324% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | -10.078% |
| Femasys Inc. | -14.5 Million USD | -14.658% |
| GlucoTrack, Inc. | -7.1 Million USD | -134.164% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 978.3% |
| Hologic, Inc. | 882.6 Million USD | 101.885% |
| ICU Medical, Inc. | 22.82 Million USD | 172.881% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 100.942% |
| KORU Medical Systems, Inc. | -10.26 Million USD | -61.977% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 144.86% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -141.068% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -141.068% |
| Masimo Corporation | 136.5 Million USD | 112.187% |
| Microbot Medical Inc. | -9.85 Million USD | -68.798% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 213.357% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 113.421% |
| Nephros, Inc. | -1.59 Million USD | -944.256% |
| NovoCure Limited | -232.87 Million USD | 92.857% |
| NEXGEL, Inc. | -3.47 Million USD | -378.43% |
| NEXGEL, Inc. | -3.47 Million USD | -378.43% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 83.818% |
| OraSure Technologies, Inc. | 54.07 Million USD | 130.761% |
| Pro-Dex, Inc. | 7.17 Million USD | 331.911% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 61.824% |
| Predictive Oncology Inc. | -13.92 Million USD | -19.493% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -510.608% |
| QuidelOrtho Corporation | 139.1 Million USD | 111.959% |
| Repligen Corporation | 54.57 Million USD | 130.48% |
| Sanara MedTech Inc. | -4.21 Million USD | -294.648% |
| STAAR Surgical Company | 28.09 Million USD | 159.206% |
| Sharps Technology, Inc. | -10.12 Million USD | -64.27% |
| Utah Medical Products, Inc. | 16.77 Million USD | 199.154% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 80.429% |
| Jin Medical International Ltd. | 2.86 Million USD | 680.17% |